| Hdfc Pharma And Healthcare Fund Datagrid | ||||||
|---|---|---|---|---|---|---|
| Category | Pharma Fund | |||||
| BMSMONEY | Rank | N/A | ||||
| Rating | N/A | |||||
| Growth Option 13-03-2026 | ||||||
| NAV | ₹17.09(R) | -2.53% | ₹17.6(D) | -2.52% | ||
| Returns | 1Y | 3Y | 5Y | 7Y | 10Y | |
| Lumpsum | Regular | 12.89% | -% | -% | -% | -% |
| Direct | 14.22% | -% | -% | -% | -% | |
| Nifty Pharma TRI | 12.8% | 26.24% | 14.52% | 14.92% | 7.65% | |
| SIP (XIRR) | Regular | 3.36% | -% | -% | -% | -% |
| Direct | 4.6% | -% | -% | -% | -% | |
| Ratio | Sharpe Ratio | Sortino Ratio | Sterling Ratio | Jensen's Alpha | Treynor Ratio | |
| Risk | STD. Dev | VaR 1Y95% | Max DD | Beta | Semi Devi. | |
| Fund AUM | As on: 30/12/2025 | 1976 Cr | ||||
| Top Pharma Fund | |||||
|---|---|---|---|---|---|
| Fund Name | Rank | Rating | |||
| Mirae Asset Healthcare Fund | - | ||||
NAV Date: 13-03-2026
| Scheme Name | NAV | Rupee Change | Percent Change |
|---|---|---|---|
| HDFC Pharma and Healthcare Fund - IDCW Option | 17.09 |
-0.4400
|
-2.5300%
|
| HDFC Pharma and Healthcare Fund - Growth Option | 17.09 |
-0.4400
|
-2.5300%
|
| HDFC Pharma and Healthcare Fund - IDCW Option - Direct Plan | 17.6 |
-0.4500
|
-2.5200%
|
| HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan | 17.6 |
-0.4500
|
-2.5200%
|
Review Date: 13-03-2026
Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.
Data Source: www.amfiindia.com
| KPIs* | Fund | Nifty Pharma TRI | Cat. Avg | Min | Max | Rank (In Cat.) | Performance |
|---|---|---|---|---|---|---|
| 1M Return % | -0.55 | 2.94 |
-0.25
|
-2.34 | 2.41 | 9 | 14 | Average |
| 3M Return % | -1.12 | 0.72 |
-2.50
|
-5.86 | 0.84 | 5 | 14 | Good |
| 6M Return % | -1.65 | 3.11 |
-4.13
|
-7.22 | -0.41 | 3 | 14 | Very Good |
| 1Y Return % | 12.89 | 12.80 |
8.88
|
4.82 | 12.89 | 1 | 13 | Very Good |
| 1Y SIP Return % | 3.36 |
-1.49
|
-6.58 | 4.05 | 2 | 13 | Very Good |
| KPIs* | Fund | Nifty Pharma TRI | Cat. Avg | Min | Max | Rank (In Cat.) | Performance |
|---|---|---|---|---|---|---|
| 1M Return % | -0.46 | 2.94 | -0.15 | -2.22 | 2.53 | 9 | 14 | Average |
| 3M Return % | -0.84 | 0.72 | -2.19 | -5.70 | 1.19 | 5 | 14 | Good |
| 6M Return % | -1.08 | 3.11 | -3.48 | -6.75 | 0.40 | 3 | 14 | Very Good |
| 1Y Return % | 14.22 | 12.80 | 10.38 | 6.15 | 14.22 | 1 | 13 | Very Good |
| 1Y SIP Return % | 4.60 | -0.42 | -4.99 | 5.57 | 2 | 12 | Very Good |
Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.
| Date | Hdfc Pharma And Healthcare Fund NAV Regular Growth | Hdfc Pharma And Healthcare Fund NAV Direct Growth |
|---|---|---|
| 13-03-2026 | 17.087 | 17.597 |
| 12-03-2026 | 17.53 | 18.052 |
| 11-03-2026 | 17.622 | 18.146 |
| 10-03-2026 | 17.599 | 18.122 |
| 09-03-2026 | 17.377 | 17.893 |
| 06-03-2026 | 17.532 | 18.051 |
| 05-03-2026 | 17.543 | 18.061 |
| 04-03-2026 | 17.323 | 17.835 |
| 02-03-2026 | 17.625 | 18.144 |
| 27-02-2026 | 17.769 | 18.291 |
| 26-02-2026 | 17.911 | 18.436 |
| 25-02-2026 | 17.721 | 18.241 |
| 24-02-2026 | 17.523 | 18.037 |
| 23-02-2026 | 17.519 | 18.032 |
| 20-02-2026 | 17.348 | 17.854 |
| 19-02-2026 | 17.367 | 17.873 |
| 18-02-2026 | 17.465 | 17.973 |
| 17-02-2026 | 17.412 | 17.918 |
| 16-02-2026 | 17.311 | 17.814 |
| 13-02-2026 | 17.181 | 17.678 |
| Fund Launch Date: 04/Oct/2023 |
| Fund Category: Pharma Fund |
| Investment Objective: To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies. |
| Fund Description: An open-ended equity scheme investing in Pharma and healthcare companies |
| Fund Benchmark: BSE Healthcare Index |
Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.